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Abstract: 
Understandings the basics of Cytochrome P450 (P450 or CYP) will help to discern drug metabolism. CYP, a super-family 
of heme-thiolate proteins, are found in almost all living organisms and is involved in the biotransformation of a diverse 
range of xenobiotics, therapeutic drugs and toxins. Here, we describe DrugMetZ DB, a database for CYP metabolizing 
drugs. The DB is implemented in MySQL, PHP and HTML.  
 
Keywords: Cytochrome P450; drug metabolizing enzymes; bioinformatics  
 
Availability: www.bicpu.edu.in/DrugMetZDB/ 
 
Background: 
Cytochrome P450 (P450 or CYP), a superfamily of heme-
thiolate proteins, are found in almost all living organisms 
and  are involved in the biotransformation of a diverse 
range of xenobiotics, including therapeutic drugs and 
countless toxins, and physiologically important hormones 
such as steroids, arachidonic acid, bile acids, and retinoic 
acid. [9] For instance cytochrome P450 CYP2C9 subtype is 
responsible for the metabolism of S-warfarin. [3] The basic 
purpose of drug metabolism in the body is to make drugs 
more water soluble and thus more readily excreted in the 
urine or bile. One common way of metabolizing drugs 
involves the alteration of functional groups on the parent 
molecule (e.g., oxidation) via the cytochrome P450 
enzymes. [8]  
 
Pharmacokinetics and drug metabolism have been shown to 
be of greater importance during drug development today. It 
is evident that drugs that are too rapidly metabolized by 
drug-metabolizing enzymes are mainly localized in the 
liver. [5] An evaluation of the mechanism for the metabolic 
clearance of 315 different drugs revealed that 56% of them 
were primarily cleared through the action of the 
cytochrome P450 enzymes, with CYP3A4 being by far the 
most important (50%) followed by CYP2D6 (20%), 
CYP2C9/19 (15%), and the remaining metabolism carried 
out by CYP2E1, CYP2A6, CYP1A2, and unidentified 
P450s. [1] The CYP mixed function monooxygenases are 
located on the smooth endoplasmic reticulum of cells 
throughout the body especially in the liver. [2] A major 
obstacle for the drug industry today is, however, the 
extensive interindividual variation in human drug 
metabolism. [4] The main causes for the variation observed 
in drug metabolism are the genetic differences. [5] These 
differences are called genetic polymorphism's and are 
linked to inherited autosomal recessive traits. [6] There are 
different isozymes of CYP, arised due to genetic variations 
which governs the metabolism of different categories of 
drugs. Hence, a database on drug and corresponding CYP 
isozymes is described. 
 
Methodology: 
Data collection and storage 
Database consists of data for different category of CYP 
isozymes and metabolizing drugs. CYP related data such as 
metabolizing drug, tissue specificity, cellular location and 
gene ID were collected from published literatures 
[reference available at every entry]. In addition, CYP 
protein sequences from Swissprot [10] were also collected. 
The IUPAC name, chemical formula, smile string, drug 
description, etc. were collected from DrugBank [7] for 
CYP associated drugs.  
 
MyISAM type of engine for MySQL database system is 
used to store data. This particular engine manages non 
transactional tables and allows high speed storage and fast 
retrieval of its data through a non-clustered index and data 
organization. At present DrugMetZ DB covers 131 drugs 
and 12 subtypes of CYP isozymes.  
 
Database design and interface 
Tables were created with different data types to hold 
dissimilar data. Each table was associated by means of 
primary key and foreign key to form a comprehensive data 
transaction. Validated data sets were stored under tables 
which are in relational database management system. PHP 
is used as an interface between HTML front end and Bioinformation by Biomedical Informatics Publishing Group                            open access 
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MySQL back end to fetch data from database for user 
friendly display. 
 
 
 
Figure 1: Over all process of database 
 
 
Figure 2: (a) Home page of DrMetZ DB (b) Shows search criteria (c) Report of Drug (d) Reference display with it’s 
PubMed link (e) BLAST search result against Cytochrome P450 database  Bioinformation by Biomedical Informatics Publishing Group                            open access 
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Utility: 
This database provides essential information about different 
categories of drugs and corresponding metabolizing. 
Cytochromal isozymes present in human body. It is a user 
friendly database, allows user to search for various drugs 
and enzymes. It displays relevant information about drugs, 
especially their chemical nature. In case of enzymes, it 
gives functional, genetic and protein level information. 
DrugMetZ DB database also gives link to major databases 
such as NCBI, Swissprot, RXLIST and related articles in 
pubmed. Blast search help clients to find sequence hits in 
Cytochrome P450 database. Key feature of this database 
provides specialized information on CYP, whereas 
databases like DrugBank [7], PharmGKB [12], ADME-AP 
[13], and KEGG [14] is generalized for drugs, enzymes, 
properties of drugs or relationship among drugs and 
diseases, respectively.  
 
Conclusion: 
Datasets held in this database collected from published 
literatures and other databases contains information for 
drugs, nucleotide and protein sequences. 
 
Future development: 
Our future update will include addition of inductors and 
inhibitors of CYP, linking with KEGG and to facilitate 
access to all human drug metabolizing CYP. 
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